However, in spite of the importance of HR alteration in hereditary breast/ovarian cancer, mutations of the pivotal HR player RAD51 are surprisingly absent from the lists of genes predisposing individuals to breast or ovarian cancer (Figure 1A and B). Here, RAD51 is linked to ovarian carcinoma.